| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 10/08/2002 | US6462170 UPAR mimicking peptide |
| 10/08/2002 | US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis |
| 10/08/2002 | US6461611 Agents for the prevention of damages caused by stress conditions |
| 10/08/2002 | CA2182486C Cyclic neurokinin a antagonists |
| 10/03/2002 | WO2002077036A2 Recombinant production of polyanionic polymers, and uses thereof |
| 10/03/2002 | WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 10/03/2002 | WO2002077024A1 Shellfish protein |
| 10/03/2002 | WO2002077017A2 Medical uses of intercellular communication facilitating compounds |
| 10/03/2002 | WO2002076489A1 Serum albumin binding moieties |
| 10/03/2002 | WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses |
| 10/03/2002 | WO2002076173A2 Inhibitors of glycosaminoglycans |
| 10/03/2002 | WO2002022657A3 Peptide antagonist of multiple chemokine receptors and uses thereof |
| 10/03/2002 | WO2002010195A3 Modified peptides with increased potency |
| 10/03/2002 | WO2001074862A3 Method for the production of bacterial toxins |
| 10/03/2002 | US20020143207 Process for the deprotection of protected thiols |
| 10/03/2002 | US20020143143 Peptides designed for the diagnosis and treatment of rheumatoid arthritis |
| 10/03/2002 | US20020143142 Genetically engineering transport proteins for use in human and veterninary medicine |
| 10/03/2002 | US20020143141 Cyclic peptide for use in the treatment of eating disorders |
| 10/03/2002 | US20020142966 For cancer therapy |
| 10/03/2002 | US20020142947 By muta-synthesis using a mutated micro-organism to influence the biosynthesis of at least one of the precursors of group B streptogramines; mutant strain employed is preferably derived from the strain S. pristinaespiralis SP92 |
| 10/03/2002 | US20020142946 Cyclosporins for the treatment of respiratory diseases |
| 10/03/2002 | US20020142357 TNF receptor action modulation |
| 10/03/2002 | US20020142348 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction |
| 10/03/2002 | US20020142346 Binding compounds and methods for identifying binding compounds |
| 10/03/2002 | US20020142297 Compositions and methods for imaging gene expression |
| 10/03/2002 | US20020142004 Immunoreactive and immunotherapeutic molecules |
| 10/03/2002 | CA2442325A1 Shellfish protein |
| 10/03/2002 | CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses |
| 10/03/2002 | CA2441287A1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 10/03/2002 | CA2440582A1 Serum albumin binding moieties |
| 10/03/2002 | CA2439409A1 Inhibitors of glycosaminoglycans |
| 10/03/2002 | CA2437287A1 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 10/02/2002 | EP1245238A2 Exotoxin ligand |
| 10/02/2002 | EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 10/02/2002 | EP1244692A2 Compositions and methods for detecting stress-inducible proteins |
| 10/02/2002 | EP1244691A1 Complementary peptide ligands generated from higher eukaryote genome sequences |
| 10/02/2002 | EP0717750B1 Double-stranded peptide nucleic acids |
| 10/02/2002 | DE10116252A1 New 2-aryl-2-triorganylsilylether compounds useful for the solid phase synthesis of peptides and peptide conjugates, may be cleaved from the solid phase substrate under practically neutral conditions |
| 10/01/2002 | US6458925 Peptide antagonists of zonulin and methods for use of the same |
| 10/01/2002 | US6458923 Modified position (7) bradykinin antagonist peptides |
| 10/01/2002 | US6458766 A pharmaceutically acceptable salt or derivatives thereof, useful for preventing or treating viral and microbial infections, of oligopeotides |
| 10/01/2002 | US6458765 Polypeptides as anticancer agents and against cell proliferation |
| 10/01/2002 | US6458552 In vitro method to detect inhibition of enzymes involved in allergies and asthma by mixing enzyme with defined peptide substrates then measuring quantity of product formed in presence and absense of test compound; drug screening |
| 10/01/2002 | US6458528 Immunoassay using purified capture polypeptides from gag precursor p55 and env precursor gp130; veterinary medicine |
| 10/01/2002 | US6458381 Lipids and their use, for example, in liposomes |
| 10/01/2002 | US6458366 Compounds and methods for diagnosis of tuberculosis |
| 10/01/2002 | US6458357 Retro-inverso neurotrophic and analgesic peptides |
| 10/01/2002 | US6458349 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 10/01/2002 | CA2168113C Therapeutic peptide derivatives |
| 10/01/2002 | CA2124087C Combinatorial strategies for polymer synthesis |
| 09/26/2002 | WO2002074981A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 09/26/2002 | WO2002074808A2 Modified insulin with reduced immunogenicity |
| 09/26/2002 | WO2002074794A2 Compositions useful in gene therapy |
| 09/26/2002 | WO2002074793A2 Novel peptides for the diagnosis of schizophrenia |
| 09/26/2002 | WO2002074783A2 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | WO2002074782A2 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses |
| 09/26/2002 | WO2002036173A3 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 09/26/2002 | WO2002030922A3 Dioxolane analogs for improved inter-cellular delivery |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137910 MN gene and protein |
| 09/26/2002 | US20020137684 Polypeptides capable of crossing the small intestine or blood brain barrier; bioavailability |
| 09/26/2002 | US20020137683 For malignant melanoma and carcinoma of colon/rectum, ovaries, lungs, and prostates; epitopic; immunogens which elicit cytotoxic T lymphocyte responses |
| 09/26/2002 | US20020137672 Radiolabeled annexins |
| 09/26/2002 | US20020137096 Solid phase synthesis; photolithography |
| 09/26/2002 | US20020137092 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto- immune antibodies |
| 09/26/2002 | US20020137023 Methods and compositions for targeting compounds to muscle |
| 09/26/2002 | CA2441388A1 Modified insulin with reduced immunogenicity |
| 09/26/2002 | CA2441095A1 Modified interferon beta with reduced immunogenicity |
| 09/26/2002 | CA2440749A1 Isolation and purification procedure of vasopeptidase peptide inhibitors |
| 09/26/2002 | CA2439315A1 Compositions useful in gene therapy |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242452A2 Chimeric natriuretic peptides |
| 09/25/2002 | EP1242447A1 Compounds and use thereof to modify transport across cell membranes |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1242109A2 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 09/25/2002 | EP0972020B1 Insulin-like growth factor agonist molecules |
| 09/25/2002 | EP0948345B1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction |
| 09/25/2002 | EP0910575B1 Method for producing peptides |
| 09/25/2002 | EP0871656B1 Dolastatin derivatives, their preparation and use |
| 09/24/2002 | US6455669 Glycoprotein for use in the treatment and prevention of bacterial infections |
| 09/24/2002 | US6455501 Wound healing compositions |
| 09/24/2002 | US6455500 Radiation therapy methods |
| 09/24/2002 | US6455251 Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof |
| 09/24/2002 | US6455244 Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agents |
| 09/24/2002 | US6455049 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 09/24/2002 | US6455047 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/19/2002 | WO2002072780A2 Igf antagonist peptides |
| 09/19/2002 | WO2002072778A2 Method for identifying inhibitors of g protein coupled receptor signaling |
| 09/19/2002 | WO2002072766A2 Induction of tumor immunity by variants of folate binding protein |
| 09/19/2002 | WO2002072629A1 Immunopotentiators |
| 09/19/2002 | WO2002072621A2 Cyclohexapeptide having antimicrobial activity |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002072619A1 INTEGRIN αIIbβ3 ACTIVATING PEPTIDES AND THEIR USE |
| 09/19/2002 | WO2002072618A1 Novel peptide ligands of leukocyte integrins |
| 09/19/2002 | WO2002072616A2 Transfection complexes |
| 09/19/2002 | WO2002072614A2 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 09/19/2002 | WO2002072612A2 Peptidic modulators of the androgen receptor |
| 09/19/2002 | WO2002072609A2 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 09/19/2002 | WO2002072602A2 Somatostatin antagonists |